Page 1 of 11

Advances in Social Sciences Research Journal – Vol. 10, No. 5

Publication Date: May 25, 2023

DOI:10.14738/assrj.105.14774.

Tochkov, K., & Williams, N. (2023). The Sad Side of Happy Pills: A Case Study on Psychiatric Medication Across a Woman’s Lifespan?

Advances in Social Sciences Research Journal, 10(5).318-328.

Services for Science and Education – United Kingdom

The Sad Side of Happy Pills: A Case Study on Psychiatric

Medication Across a Woman’s Lifespan?

Karin Tochkov

Department of Psychology and Special Education,

Texas A&M University-Commerce

Nichole Williams

Department of Psychology and Special Education,

Texas A&M University-Commerce

ABSTRACT

The use of antidepressants can have many benefits and many consequences

(American Psychiatric Association, 2010). 12.7% of Americans aged 12 and older

reported taking an antidepressant in the previous month when surveyed between

2011 and 2014 (Pratt, Brody, & Gu, 2017). The purpose of this case study is to

explore the impact these medications have on a person by exploring their role in

the life of one woman, Jane Doe and to urge caution in prescribing practices.

Keywords: SSRIs, antidepressant, case-study, forced treatment, patient experiences

INTRODUCTION

Between 2011 and 2014, 12.7% of Americans 12 years and older took antidepressant

medication in the past month (Pratt, Brody, & Gu, 2017). One class of such medications are

selective serotonin reuptake inhibitors (SSRIs) which have been shown to potentially cause

many side effects in the individual taking them including such side effects as sleep disturbances,

sexual dysfunction, and more (Ferguson, 2001; Crawford et al., 2014; Liebert & Gavey, 2008).

There have also been studies to show different concerns by age group interacting with SSRIs

(Saypol, 2005; Oberlander & Miller, 2011; National Institute of Mental Health (NIMH), n.d.). The

purpose of this article is to discuss SSRI use across the lifespan, from in utero exposure through

adulthood. Specifically, the discussion will explore these shifting factors through the lens of one

person, Jane Doe’s, experiences. This story is Jane’s own and is reported as she describes it,

complete with her opinions. Interwoven is research elaborating on her experiences in relation

to what we know about SSRIs. Additionally, there will be some discussion of tricyclic

antidepressants. The aim of this paper is to show the complicated role these medications play

in the lives of those prescribed them and to urge caution in prescribing practices, by exploring

their use in the context of an individual’s life.

METHODOLOGY

The authors followed the case study methodology outlined by Yin (2017). Jane offered to share

her story with the researchers after one researcher presented at a conference. Jane spoke with

the researcher and described how mental health care had shaped her life. Jane was asked if she

would be willing to be interviewed about her experiences.

Page 2 of 11

319

Tochkov, K., & Williams, N. (2023). The Sad Side of Happy Pills: A Case Study on Psychiatric Medication Across a Woman’s Lifespan? Advances in

Social Sciences Research Journal, 10(5).318-328.

URL: http://dx.doi.org/10.14738/assrj.105.14774

When designing the case study, the following aspects were discussed: developing the question,

obtaining consent, deciding on the structure of the interview, and deciding on how to use the

interview to answer the research question. The research question was to obtain a detailed

report about the traumatic consequences the mental health system had on an individual person.

From there, we conducted the case study interview. To do this, the researchers obtained

written consent from the subject vie e-mail correspondence before the phone interview took

place. Jane interviewed on the phone with the second author regarding her experiences in the

mental health system. Jane was asked to describe the experiences she endured over many years

of her life. The interview was unstructured with the only additional questions being those

needed to clarify something Jane reported, such as asking her age at the time of an event

reported.

While she shared her story, the interviewer wrote her story down. The story was recorded as

she spoke with the aim of documenting her story as accurately as possible and using her own

words whenever able. To do this, her story was recorded by the researcher in a bulleted format

as she presented it and exact quotes were written whenever possible. Additionally, an audio

recording was made that was used to ensure the notation was accurate and thorough. Once the

interview was completed, the notes were formed into the chronological narrative that follows.

Steps taken to address subject anonymity were assigning her the pseudonym, Jane, and never

writing down the subject’s real name in any of the notes the researchers took or using it in the

recording. Once her story was organized chronologically, the researchers collected literature

related to the experiences Jane had in an effort to educate on potential causes of the challenges

she faced and to inform others of the complexity of psychiatric medication prescribing. Prior to

submitting it to publication, the article was shared with her to ensure it was true to her story.

JANE’S FAMILY

Jane Doe is currently a 36-year-old married, mother of one. She comes from a very religious and

evangelical family. She was the second born and has an older sister that is 5 years older. Her

parents had a troubled marriage that eventually resulted in divorce. She was an intelligent and

friendly child that did well in school and made friends easily. Her family did not believe in

expressing emotions. According to Jane, they tended to believe if you were suffering, it was

because you did not pray hard enough. Her mother was also a strong believer in doctors and,

according to Jane, almost worshipped them in a religious way. As a child, Jane viewed herself as

being a highly sensitive and empathic child that picked up on the negative emotions not

expressed in her house.

Exposure to Tricyclic Antidepressants While Nursing

Jane Doe’s mother was diagnosed with postpartum depression shortly after giving birth to her.

There appears to be a family history of this, but an additional factor was her mother’s

experience of sexual trauma as a child that was never dealt with. In response to this diagnosis,

Jane’s mother was prescribed an antidepressant, amitriptyline, which is a tricyclic

antidepressant. Research covering long-term effects of antidepressant exposure as a nursing

infant is non-existent to the knowledge of the authors, but there is research showing exposure

to tricyclic antidepressants result in low levels of the medication or its metabolite are

detectable in the infant exposed (Eberhard-Gran, Eskild, & Opjordsmoen, 2006; Burt et al.,

2001). One tricyclic antidepressant in particular, doxepin, has shown up in high levels and

Page 3 of 11

320

Advances in Social Sciences Research Journal (ASSRJ) Vol. 10, Issue 5, May-2023

Services for Science and Education – United Kingdom

resulted in anecdotal evidence of respiratory depression and sedation in the infant (Eberhard- Gran, Eskild, & Opjordsmoen, 2006; Burt et al., 2001).

Jane Doe considers nursing to be her first exposure to antidepressants and evidence does

support that at least some of the medication her mother was taking could be detectable in her

system (Eberhard-Gran, Eskild, & Opjordsmoen, 2006; Burt et al., 2001). How this impacted her

in the long term is difficult to say due to the lack of evidence of long-term outcomes of children

exposed to antidepressants during nursing. This is important in terms of current practice,

because the American Psychological Association (APA) charges clinicians with doing good or at

the very least doing no harm (2017). If there is limited information available on potential

outcomes, potential adverse events must be weighed.

Childhood Exposure to Medications

Jane recalls very early feeling her mom’s sorrow and thinking it was her own fault. Around 5

years old, she says she began to mirror the conflict and emotions she sensed back to her parents.

Jane’s mother continued with her antidepressant for a long time until Jane was about 7 years

old. Jane’s father did not support taking psychiatric medications and had pushed her mother to

stop taking them. Her mother was hospitalized for depression due to suicidal thoughts. Jane

now feels this was due at least in part to withdrawal from the medication. Research does

support that her mother could have suffered discontinuation syndrome from stopping her

medication (Haddad & Anderson, 2007, Warner, Bobo, Warner, Reid, & Rachal, 2006;

Yerevanian, Koek, Feusner, Hwang, & Mintz, 2004; Maxiner & Greden, 1998). Discontinuation

syndrome from stopping tricyclic antidepressants can result in several symptoms including

somatic symptoms, problems with sleep, gastrointestinal distress, and affective symptoms

(Haddad & Anderson, 2007, Warner et al., 2006; Maxiner & Greden, 1998). The affective

symptoms can include anxiety, irritability, tearfulness, and/or a generally low mood (Haddad

& Anderson, 2007, Warner et al., 2006; Maxiner & Greden, 1998).

Her mother’s hospitalization was very distressing to her. Nobody explained why her mother

was gone. Jane feels that affected her attachment to her mother. She began to have insomnia,

anxiety, and get upset when her mother would leave the room. She attributes these behaviors

to developing an insecure attachment with her mother.

These behaviors worried her mother and she took Jane to the pediatrician. The pediatrician

prescribed her the same antidepressant her mom had taken, Elavil. This was in about 1987 and

Jane says she was a “guinea pig” because there was limited knowledge of medication side effects

in children. After beginning the medication, she began to care less about school, withdrew

socially, become argumentative, and she had increased daytime anxiety. Increased anxiety,

changes in mood, and changes in behavior are all potential side effects for amitriptyline

(MedlinePlus, 2017a). Not long after she became very sick with mono and once, she recovered,

her doctor switched her to fluoxetine and trazodone. Upon starting these medications, she

began to feel excessively “hyped up” and jittery. She struggled to concentrate, which had never

been an issue in the past. Another troubling side effect was that the medication “killed” her

appetite. This combination of medications is troubling and explains Jane’s experience.

Fluoxetine and trazodone both have the potential of, but are not limited to, loss of appetite,

decreased ability to concentrate, anxiety, and nervousness (MedlinePlus, 2017b; MedlinePlus,

2017c). Additionally, these two medications can have troubling interactions such as chest pain